Clincosm LogoSign in Get a demo

Chronic Obstructive Pulmonary Disease

Showing NaN - NaN of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Trial in Australia, New Zealand, United States (PT003 MDI, PT005 MDI, Placebo MDI)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • PT003 MDI
  • +5 more
  • Clearwater, Florida
  • +15 more
Mar 14, 2017

COPD Trial in Worldwide (Aclidinium bromide/formoterol Fixed-Dose Combination (FDC), Aclidinium bromide, Formoterol Fumarate)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)
  • +3 more
  • Anniston, Alabama
  • +207 more
Mar 9, 2017

COPD Trial in Canada, United States (Aclidinium Bromide 200 µg, Aclidinium Bromide 400 µg)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium Bromide 200 µg
  • Aclidinium Bromide 400 µg
  • Birmingham, Alabama
  • +112 more
Mar 9, 2017

COPD Trial in Worldwide (carmoterol (CHF 4226), salmeterol, )

Completed
  • Chronic Obstructive Pulmonary Disease
  • carmoterol (CHF 4226)
  • +2 more
  • Jonesboro, Arkansas
  • +49 more
Apr 7, 2017

COPD Trial in Australia, New Zealand, United States (GFF MDI, GP MDI, FF MDI)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • GFF MDI
  • +4 more
  • Andalusia, Alabama
  • +139 more
Feb 7, 2017

COPD Trial in Worldwide (Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium Bromide/Formoterol Fumarate
  • +3 more
  • Anniston, Alabama
  • +221 more
Feb 2, 2017

COPD Trial in United States (Aclidinium 400 µg / Formoterol 12 µg, Aclidinium 400 µg / Formoterol 6 µg, Aclidinium 400 µg)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium 400 μg / Formoterol 12 μg
  • +4 more
  • Glendale, Arizona
  • +19 more
Jan 16, 2017

COPD Trial in Worldwide (MEDI8968 600 mg IV, 300 mg SC, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • MEDI8968 600 mg IV, 300 mg SC
  • Placebo
  • Peoria, Arizona
  • +59 more
Nov 30, 2016

COPD Trial in Canada, United States (Aclidinium bromide, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide
  • Placebo
  • Birmingham, Alabama
  • +111 more
Nov 30, 2016

COPD Trial in Canada, United States (Aclidinium bromide)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide
  • Birmingham, Alabama
  • +82 more
Nov 16, 2016

COPD Trial in Canada, United States (Aclidinium bromide, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide
  • Placebo
  • Birmingham, Alabama
  • +111 more
Nov 16, 2016

COPD Trial in United States (PT003, PT001, PT005)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Glendale, Arizona
  • +18 more
May 23, 2016

COPD Trial in United States (NVA237, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Homewood, Alabama
  • +53 more
Feb 12, 2015

COPD Trial in United States (Arformoterol, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Birmingham, Alabama
  • +72 more
Sep 12, 2013

COPD Trial in United States (Fluticasone Propionate/Formoterol Fumarate, Formoterol Fumarate, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Fluticasone Propionate/Formoterol Fumarate
  • +2 more
  • Phoenix, Arizona
  • +22 more
May 17, 2013

COPD Trial in Clearwater, Tampa, Spartanburg (PT005 MDI, Formoterol Fumarate 12 µg (Foradil® Aerolizer®), Formoterol Fumarate 24

Completed
  • Chronic Obstructive Pulmonary Disease
  • PT005 MDI
  • +3 more
  • Clearwater, Florida
  • +2 more
Sep 10, 2012

COPD, Chronic Bronchitis, Emphysema Trial in United States (arformoterol tartrate inhalation solution, Salmeterol, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • +2 more
  • arformoterol tartrate inhalation solution
  • +2 more
  • Jasper, Alabama
  • +64 more
Feb 21, 2012

COPD, Chronic Bronchitis, Emphysema Trial in United States (arformoterol, Salmeterol)

Completed
  • Chronic Obstructive Pulmonary Disease
  • +2 more
  • Anniston, Alabama
  • +89 more
Feb 21, 2012

COPD Trial in United States (Indacaterol, Salmeterol 50 µg, Placebo to indacaterol)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Florence, Alabama
  • +68 more
Jul 22, 2011

COPD Trial in United States (Indacaterol, Placebo to indacaterol)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Anniston, Alabama
  • +53 more
Jul 22, 2011

COPD Trial in Belgium, New Zealand, United States (Indacaterol 150 µg, Placebo to indacaterol)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Indacaterol 150 μg
  • Placebo to indacaterol
  • Anniston, Alabama
  • +119 more
Jul 22, 2011

Diabetes, COPD Trial in Worldwide (Subcutaneous Insulin, Inhaled Insulin)

Terminated
Has Results
  • Diabetes Mellitus
  • Chronic Obstructive Pulmonary Disease
  • Subcutaneous Insulin
  • Inhaled Insulin
  • Glendale, Arizona
  • +87 more
Jan 25, 2010

COPD Trial in United States (Fluticasone Propionate/Formoterol Fumarate, Fluticasone Propionate, Formoterol Fumarate)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Fluticasone Propionate/Formoterol Fumarate
  • +4 more
  • Birmingham, Alabama
  • +48 more
Jun 26, 2009

COPD Trial in Worldwide (Budesonide/formoterol pMDI, Formoterol Turbuhaler)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Budesonide/formoterol pMDI
  • Formoterol Turbuhaler
  • Birmingham, Alabama
  • +215 more
Mar 26, 2009

COPD Trial in Worldwide (Budesonide/formoterol pMDI, Budesonide pMDI, Formoterol Turbuhaler)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Budesonide/formoterol pMDI
  • +2 more
  • Birmingham, Alabama
  • +214 more
Mar 26, 2009